Latest News

In first for EU, anti-skin cancer drug approved



French pharmaceutical giant Sanofi on Friday said the European Medicines Agency had conditionally approved its anti-cancer drug Libtayo, the first drug of its kind to be authorised for use in the EU.

Source link

Related posts

FDA Recalls Insulin Pumps Over Security Concerns

Newsemia

Green Coffee For Weight Loss: Does It Work?

Newsemia

Evolution of cranial shape in a continentalā€scale evolutionary radiation of Australian lizards

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World